Fig. 4
- ID
- ZDB-FIG-230605-4
- Publication
- Wu et al., 2022 - Assessment of stromal SCD-induced drug resistance of PDAC using 3D-printed zPDX model chips
- Other Figures
- All Figure Page
- Back to All Figure Page
Assembly of the zPDX microarray chips to assess their responses to chemotherapy (A) 3D-printed molds of separated PDMS wells, agarose mini-capsules, and the covers of the well. Two holes on each cover to add drugs and replace the solution every 6 h. (B) The representative scanning images of a zPDX model chip at 0 hpt (hours post drug treatment) and 60 hpt in green and red fluorescent channels, and a representative quantitative analysis for the fluorescent signals of the tumor cells (red) and the fibroblasts (green). (C) Summarized heatmap of the normalized viability of PDAC tumor cells in the drug-treated groups compared to the DMSO-treated control group. GEM: Gemcitabine; PTX: Paclitaxel; CPT-11: Irinotecan; NVB: Vinorelbine; DDP: Cisplatin; TGO: Tegafur. Scale bar: 300 μm. |